About us

Biology for people. Natural molecules or derivatives make up more than half of the current drugs on the market with applications to nearly every disease known to humans. Salicylic acid, morphine, cannabinoids and insulin are a few examples. Our specialty is in producing these, and new targets, using a fast and scalable platform based on engineered microbes. We use the technologies from traditional and modern biology combined with computational analysis to develop our organisms at the fastest possible speed. This makes our platform faster and cheaper than chemical synthesis or extraction from the natural source.

Website
http://hyasynthbio.com
Industry
Biotechnology Research
Company size
11-50 employees
Type
Privately Held
Founded
2014
Specialties
biology, biosynthesis, cannabis, cannabinoid, cannabidiol, cbd, clean beauty, personal care, fermentation, wellness, sustainability, and yeast

Employees at Hyasynth Bio

Updates

Similar pages

Browse jobs

Funding

Hyasynth Bio 11 total rounds

Last Round

Debt financing

US$ 1.9M

Investors

OrganiGram
See more info on crunchbase